Market Closed -
Toronto S.E.
04:56:58 2024-06-11 pm EDT
|
5-day change
|
1st Jan Change
|
10.07
CAD
|
+0.90%
|
|
-5.71%
|
+48.96%
|
Fiscal Period: Marzo |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Capitalization
1 |
7,154
|
15,424
|
3,737
|
1,215
|
1,062
|
767.3
|
-
|
-
|
Enterprise Value (EV)
1 |
5,643
|
14,708
|
3,866
|
1,739
|
1,456
|
1,202
|
1,284
|
767.3
|
P/E ratio
|
-5.38
x
|
-8.61
x
|
-12.3
x
|
-0.34
x
|
-1.33
x
|
-7.21
x
|
-9.2
x
|
-26.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
17.9
x
|
28.2
x
|
7.18
x
|
3.02
x
|
3.09
x
|
2.52
x
|
2.37
x
|
2.1
x
|
EV / Revenue
|
14.2
x
|
26.9
x
|
7.43
x
|
4.32
x
|
4.23
x
|
3.95
x
|
3.97
x
|
2.1
x
|
EV / EBITDA
|
-12.7
x
|
-43.2
x
|
-9.31
x
|
-4.97
x
|
-24.7
x
|
-49.1
x
|
-2,054
x
|
34.5
x
|
EV / FCF
|
-3.82
x
|
-23.3
x
|
-6.64
x
|
-3.07
x
|
-5.1
x
|
-9.45
x
|
-17.5
x
|
38.9
x
|
FCF Yield
|
-26.2%
|
-4.28%
|
-15.1%
|
-32.6%
|
-19.6%
|
-10.6%
|
-5.72%
|
2.57%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
34,965
|
38,216
|
39,417
|
51,264
|
91,115
|
76,198
|
-
|
-
|
Reference price
2 |
204.6
|
403.6
|
94.80
|
23.70
|
11.66
|
10.07
|
10.07
|
10.07
|
Announcement Date
|
5/29/20
|
6/1/21
|
5/27/22
|
6/22/23
|
5/30/24
|
-
|
-
|
-
|
Fiscal Period: Marzo |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net sales
1 |
398.8
|
546.6
|
520.3
|
402.9
|
343.9
|
304
|
323.4
|
364.9
|
EBITDA
1 |
-442.8
|
-340.3
|
-415.4
|
-349.7
|
-58.92
|
-24.47
|
-0.6254
|
22.25
|
EBIT
1 |
-1,046
|
-1,134
|
-713.3
|
-2,848
|
-228.7
|
-90.35
|
-62.3
|
-21.82
|
Operating Margin
|
-262.23%
|
-207.44%
|
-137.09%
|
-706.94%
|
-66.5%
|
-29.73%
|
-19.26%
|
-5.98%
|
Earnings before Tax (EBT)
1 |
-1,509
|
-1,684
|
-329.4
|
-3,314
|
-471.4
|
-151.8
|
-113.4
|
-75.5
|
Net income
1 |
-1,321
|
-1,745
|
-302.2
|
-3,278
|
-657.3
|
-127.6
|
-100.7
|
-46.26
|
Net margin
|
-331.35%
|
-319.2%
|
-58.08%
|
-813.63%
|
-191.1%
|
-41.98%
|
-31.15%
|
-12.68%
|
EPS
2 |
-38.00
|
-46.90
|
-7.700
|
-70.70
|
-8.790
|
-1.397
|
-1.095
|
-0.3750
|
Free Cash Flow
1 |
-1,478
|
-630.2
|
-582.5
|
-566.8
|
-285.4
|
-127.1
|
-73.46
|
19.73
|
FCF margin
|
-370.53%
|
-115.29%
|
-111.95%
|
-140.67%
|
-82.98%
|
-41.82%
|
-22.71%
|
5.41%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
88.68%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/29/20
|
6/1/21
|
5/27/22
|
6/22/23
|
5/30/24
|
-
|
-
|
-
|
Fiscal Period: Marzo |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
2026 Q1
|
---|
Net sales
1 |
141
|
111.8
|
110.1
|
117.9
|
101.2
|
87.54
|
108.7
|
69.6
|
90.06
|
83.15
|
73.72
|
70.22
|
77.35
|
79.51
|
77.14
|
EBITDA
1 |
-67.41
|
-121.8
|
-74.8
|
-78.1
|
-87.5
|
-95.64
|
-57.84
|
-11.86
|
-8.989
|
-15.09
|
-7.332
|
-4.892
|
0.3151
|
2.711
|
-3.4
|
EBIT
1 |
-150
|
-288.5
|
-110.2
|
-175.8
|
-153.8
|
-604.7
|
-87.48
|
-36.9
|
-60.32
|
-106.7
|
-25.41
|
-22.57
|
-17.85
|
-15.37
|
-
|
Operating Margin
|
-106.38%
|
-258.12%
|
-100.12%
|
-149.2%
|
-151.92%
|
-690.82%
|
-80.45%
|
-53.02%
|
-66.97%
|
-128.36%
|
-34.47%
|
-32.14%
|
-23.07%
|
-19.34%
|
-
|
Earnings before Tax (EBT)
1 |
-115.7
|
-587.1
|
-2,084
|
-223.7
|
-267.1
|
-664
|
-39.84
|
-135.3
|
-231.4
|
-96.11
|
-41.95
|
-38.1
|
-32.7
|
-28.68
|
-
|
Net income
1 |
-108.9
|
-574.6
|
-2,083
|
-221.8
|
-261.6
|
-640.1
|
-38.12
|
-310
|
-216.8
|
-82.34
|
-35.63
|
-32.74
|
-28.69
|
-23.06
|
-
|
Net margin
|
-77.27%
|
-514.11%
|
-1,891.79%
|
-188.19%
|
-258.45%
|
-731.23%
|
-35.06%
|
-445.45%
|
-240.72%
|
-99.02%
|
-48.33%
|
-46.62%
|
-37.09%
|
-29%
|
-
|
EPS
2 |
-2.800
|
-14.60
|
-52.30
|
-4.700
|
-5.400
|
-12.80
|
-0.7000
|
-4.300
|
-2.620
|
-1.030
|
-0.4750
|
-0.4225
|
-0.3625
|
-0.2850
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/9/22
|
5/27/22
|
8/5/22
|
11/9/22
|
2/9/23
|
6/22/23
|
8/9/23
|
11/9/23
|
2/9/24
|
5/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: Marzo |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net Debt
1 |
-
|
-
|
129
|
524
|
394
|
434
|
517
|
-
|
Net Cash position
1 |
1,511
|
716
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.3113
x
|
-1.499
x
|
-6.683
x
|
-17.75
x
|
-826.7
x
|
-
|
Free Cash Flow
1 |
-1,478
|
-630
|
-582
|
-567
|
-285
|
-127
|
-73.5
|
19.7
|
ROE (net income / shareholders' equity)
|
-21.7%
|
-27.3%
|
-8.55%
|
-151%
|
-104%
|
-26.9%
|
-10.7%
|
-5.5%
|
ROA (Net income/ Total Assets)
|
-17.1%
|
-17.2%
|
-4.86%
|
-81.5%
|
-35.1%
|
-8.8%
|
-5.4%
|
-3.4%
|
Assets
1 |
7,711
|
10,167
|
6,219
|
4,022
|
1,870
|
1,450
|
1,866
|
1,361
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
2 |
-22.20
|
-12.50
|
-
|
-12.00
|
-3.770
|
1.440
|
0.7800
|
0.1400
|
Capex
1 |
705
|
165
|
36.7
|
9.22
|
3.45
|
5.2
|
5.3
|
10.8
|
Capex / Sales
|
176.78%
|
30.09%
|
7.05%
|
2.29%
|
1%
|
1.71%
|
1.64%
|
2.95%
|
Announcement Date
|
5/29/20
|
6/1/21
|
5/27/22
|
6/22/23
|
5/30/24
|
-
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
10.07
CAD Average target price
8.89
CAD Spread / Average Target -11.72% Consensus |
1st Jan change
|
Capi.
|
---|
| +48.96% | 557M | | +41.81% | 6.21B | | -22.93% | 4.1B | | +9.84% | 3.43B | | -18.80% | 2.85B | | -10.82% | 2.29B | | +48.92% | 1.98B | | -7.03% | 1.53B | | +49.25% | 1.54B | | -15.60% | 1.54B |
Alternative Medicine
|